{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:50:07Z","timestamp":1794628207415,"version":"4.9.1"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","award":["not available"],"award-info":[{"award-number":["not available"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2025,10,22]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the annual trends over two decades in hypertension diagnosis, true hypertension prevalence, and control and use of antihypertensive drugs in England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Annual, representative, nationwide Health Surveys for England from 2003 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Nationally representative sample consisting of participants from private households, identified through stratified, national, multistage sampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>67\u2009242 people older than 16 years surveyed between 2003 and 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2003 and 2021, the prevalence of measured hypertension decreased significantly from 37.8% in 2003 to 33.2% in 2018 (average annual percentage change (AAPC) \u22120.9%, 95%\u2009confidence interval \u22121.6% to \u22120.6%). Mean population systolic and diastolic blood pressure decreased significantly between 2003 to 2019 (systolic blood pressure from 128.7 to 124.0\u2009mm Hg, AAPC \u22120.15%, \u22120.21% to \u22120.11%; diastolic blood pressure from 73.7 to 71.8\u2009mm Hg, AAPC \u22120.12%, \u22120.20% to \u22120.04%). The prevalence of those with undiagnosed hypertension in the community decreased from 32.6% in 2003 to 23.7% in 2011, gradually worsening thereafter, with a steep increase in 2021 when 32.4% of those with hypertension were undiagnosed (AAPC \u22121.04%, \u22121.92% to \u22120.22%). Among people diagnosed (known) with hypertension, the proportion of those with blood pressure controlled to target increased across the study period (AAPC 1.66%, 0.04%\u2009to 2.27%), but this was mainly driven by the significant increase from 47.3% in 2003 to 56.5% in 2009 (AAPC 3.62%, 1.52%\u2009to 5.74%). A plateau was observed from 2011 onwards when there was no further significant improvement in the proportion of people with diagnosed (known) hypertension and blood pressure controlled to target. People with diagnosed (known) but uncontrolled hypertension showed a small but significant decrease in the mean number (standard deviation) of antihypertensive drugs used during the study period from 2.17 (0.86) in 2003 to 2.14 (0.96) in 2021 (AAPC \u22120.18%, \u22120.68% to \u22120.03%). Those with diagnosed (known) and controlled hypertension had no significant change in the mean number of drugs used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate that there was a significant improvement in hypertension prevalence and control in the 2000s, with a plateau after 2011. The prevalence of undiagnosed hypertension in the community reduced in the early 2000s and 2010s, but has since returned to the same level as two decades ago.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjmed-2025-001556","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:15:25Z","timestamp":1764249325000},"page":"e001556","source":"Crossref","is-referenced-by-count":9,"title":["Trends in hypertension prevalence, control, and antihypertensive use in England from 2003 to 2021: insights from annual, nationwide Health Surveys for England"],"prefix":"10.1136","volume":"4","author":[{"given":"Catherine","family":"Graham","sequence":"first","affiliation":[{"name":"William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London, UK"},{"name":"Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8314-6630","authenticated-orcid":false,"given":"James","family":"Steckelmacher","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London, UK"},{"name":"Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Prashar","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London, UK"},{"name":"Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Ahmed","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Capel","sequence":"additional","affiliation":[{"name":"London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R","family":"Poulter","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Sedgwick","family":"Sever","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5807-8503","authenticated-orcid":false,"given":"Ajay Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London, UK"},{"name":"Barts Health NHS Trust, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"NIHR Barts Biomedical Research Centre, Barts Health NHS Trust and Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"2025112705152136000_4.1.e001556.1","unstructured":"Global report on hypertension: the race against a silent killer. 2018. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240081062"},{"key":"2025112705152136000_4.1.e001556.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32203-7"},{"key":"2025112705152136000_4.1.e001556.3","first-page":"795","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2019","journal-title":"Lancet Neurol"},{"key":"2025112705152136000_4.1.e001556.4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-6175.2003.02463.x","article-title":"The economic impact of hypertension","volume":"5","author":"Elliott","year":"2003","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025112705152136000_4.1.e001556.5","unstructured":"Risk factors for undiagnosed high blood pressure in England - office for national statistics. 2024. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthandwellbeing\/articles\/riskfactorsforundiagnosedhighbloodpressureinengland\/2015to2019"},{"key":"2025112705152136000_4.1.e001556.6","unstructured":"Veena R , Danielle J , Dan W . Cardiovascular disease in England: supporting leaders to take actions - smart thinking. 2022."},{"key":"2025112705152136000_4.1.e001556.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60688-7"},{"key":"2025112705152136000_4.1.e001556.8","unstructured":"British Heart Foundation . Early heart disease deaths rise to 14-year high - BHF. 2024. Available: https:\/\/www.bhf.org.uk\/what-we-do\/news-from-the-bhf\/news-archive\/2024\/january\/early-heart-disease-deaths-rise-to-14-year-high"},{"key":"2025112705152136000_4.1.e001556.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"2025112705152136000_4.1.e001556.10","unstructured":"National Institute for Health and Care Excellence . CG127: the clinical management of primary hypertension in adults. 2011."},{"key":"2025112705152136000_4.1.e001556.11","unstructured":"NHS Digital . Health Survey for England - NHS England. 2024. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/health-survey-for-england"},{"key":"2025112705152136000_4.1.e001556.12","doi-asserted-by":"publisher","DOI":"10.1080\/02664763.2022.2063265"},{"key":"2025112705152136000_4.1.e001556.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-17282-3","article-title":"The impact of the COVID-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis","volume":"23","author":"Castanon","year":"2023","journal-title":"BMC Public Health"},{"key":"2025112705152136000_4.1.e001556.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02158-7"},{"key":"2025112705152136000_4.1.e001556.15","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X693077"},{"key":"2025112705152136000_4.1.e001556.16","doi-asserted-by":"crossref","unstructured":"He FJ , MacGregor GA . Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004;CD004937. doi:10.1002\/14651858.CD004937","DOI":"10.1002\/14651858.CD004937"},{"key":"2025112705152136000_4.1.e001556.17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/HJH.0000000000003521","article-title":"Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018","volume":"41","author":"Song","year":"2023","journal-title":"J Hypertens"},{"key":"2025112705152136000_4.1.e001556.18","unstructured":"Public Health England . Salt Reduction Targets for 2024. UK Government, 2020."},{"key":"2025112705152136000_4.1.e001556.19","unstructured":"NHS Digital . Statistics on obesity, physical activity and diet, England, 2020 - NHS England. 2020. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/statistics-on-obesity-physical-activity-and-diet\/england-2020"},{"key":"2025112705152136000_4.1.e001556.20","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2017.75"},{"key":"2025112705152136000_4.1.e001556.21","first-page":"397","article-title":"Soft drinks levy reduces sugar consumption","volume":"230","author":"Hellyer","year":"2021","journal-title":"Br Dent J"},{"key":"2025112705152136000_4.1.e001556.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.o1079","article-title":"New calorie labelling regulations in England","volume":"377","author":"Kaur","year":"2022","journal-title":"BMJ"},{"key":"2025112705152136000_4.1.e001556.23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/HYPERTENSIONAHA.124.22703","article-title":"Alcohol Intake and Risk of Hypertension: A Systematic Review and Dose-Response Meta-Analysis of Nonexperimental Cohort Studies","volume":"81","author":"Cecchini","year":"2024","journal-title":"Hypertension"},{"key":"2025112705152136000_4.1.e001556.24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/HYPERTENSIONAHA.118.11190","article-title":"Sitting Less and Moving More: Implications for Hypertension","volume":"72","author":"Dempsey","year":"2018","journal-title":"Hypertension"},{"key":"2025112705152136000_4.1.e001556.25","unstructured":"Sport England . Active lives survey | results. 2024. Available: https:\/\/activelives.sportengland.org\/Result?viewStateId=4"},{"key":"2025112705152136000_4.1.e001556.26","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835080b7"},{"key":"2025112705152136000_4.1.e001556.27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000443933","article-title":"Psychological Distress and Hypertension: Results from the National Health Interview Survey for 2004-2013","volume":"6","author":"Ojike","year":"2016","journal-title":"Cardiorenal Med"},{"key":"2025112705152136000_4.1.e001556.28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S0033291723002349","article-title":"Temporal patterns in the recorded annual incidence of common mental disorders over two decades in the United Kingdom: a primary care cohort study","volume":"54","author":"Dykxhoorn","year":"2024","journal-title":"Psychol Med"},{"key":"2025112705152136000_4.1.e001556.29","doi-asserted-by":"crossref","first-page":"102438","DOI":"10.1016\/j.cpcardiol.2024.102438","article-title":"Association of neighborhood deprivation and hypertension: A systematic review and meta-analysis","volume":"49","author":"Satapathy","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"2025112705152136000_4.1.e001556.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m693","article-title":"Health equity in England: the Marmot review 10 years on","volume":"368","author":"Marmot","year":"2020","journal-title":"BMJ"},{"key":"2025112705152136000_4.1.e001556.31","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2296-15-130","article-title":"The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review","volume":"15","author":"Lebeau","year":"2014","journal-title":"BMC Fam Pract"},{"key":"2025112705152136000_4.1.e001556.32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jch.14699","article-title":"Uncontrolled blood pressure and therapeutic inertia in treated hypertensive patients: A retrospective cohort study using a UK general practice database","volume":"25","author":"Darricarrere","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025112705152136000_4.1.e001556.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002513","article-title":"Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study","volume":"15","author":"Tran","year":"2018","journal-title":"PLoS Med"},{"key":"2025112705152136000_4.1.e001556.34","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-322118"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2025-001556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:15:34Z","timestamp":1764249334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2025-001556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,27]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjmed-2025-001556"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2025-001556","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}